Can-Fite BioPharma Debt to Equity Ratio Trends

Can-Fite BioPharma Ltd. (CANF)

3.28 -0.05 (-1.50%) USD | NYAM | Aug 24, 16:00

3.28 0.00 (0.00%) After-Hours: 20:00

Debt to Equity Ratio Chart

View Debt to Equity Ratio for CANF.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Debt to Equity Ratio Chart

Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to . Start Trial.

Date	Value

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks

Start Trial

BioLineRx Ltd.	0.544
XTL Biopharmaceuticals Ltd.	--
Kamada Ltd.	0.0438
Galmed Pharmaceuticals Ltd.	0.00
Revium Recovery, Inc.	--